Long-term safety and effectiveness of adalimumab in 462 patients with intestinal Behçet’s disease: results from a large real-world observational study

BACKGROUND/AIMS: The safety and effectiveness of adalimumab was demonstrated in a phase 3 trial in Japanese patients with intestinal Behçet’s disease. The aim of this study was to evaluate the long-term safety and effectiveness of adalimumab in Japanese patients with intestinal Behçet’s disease. MET...

Descripción completa

Detalles Bibliográficos
Autores principales: Suzuki, Yasuo, Hagiwara, Takashi, Kobayashi, Mariko, Morita, Kazuo, Shimamoto, Tomoyo, Hibi, Toshifumi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Association for the Study of Intestinal Diseases 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8322033/
https://www.ncbi.nlm.nih.gov/pubmed/32814420
http://dx.doi.org/10.5217/ir.2020.00013

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8322033/
https://www.ncbi.nlm.nih.gov/pubmed/32814420
http://dx.doi.org/10.5217/ir.2020.00013

Ejemplares similares